Back | Next |
home / stock / atos / atos message board
Subject | By | Source | When |
---|---|---|---|
You called it | Jdanger 2 | investorshub | 08/04/2021 2:49:05 PM |
Nice entry point | slugo1 | investorshub | 08/02/2021 4:53:52 PM |
It will bounce back hard! | ttottip | investorshub | 07/30/2021 4:37:52 PM |
What great prices! | ttottip | investorshub | 07/30/2021 4:25:50 PM |
Yes, this needs to be discussed openly, and | XenaLives | investorshub | 07/30/2021 3:33:47 PM |
https://youtu.be/2il4GtbRRUg | MuskVoice | investorshub | 07/30/2021 2:26:23 PM |
Why all this old news | the_aaardvark | investorshub | 07/30/2021 2:02:26 PM |
Head and shoulders goes down the drain. | willlbone | investorshub | 07/30/2021 1:58:34 PM |
Atossa Therapeutics Phase 2 Endoxifen Breast Cancer Study | XenaLives | investorshub | 07/29/2021 5:42:15 AM |
Atossa Therapeutics Receives $21 Million from Recent Exercises | XenaLives | investorshub | 07/29/2021 5:40:05 AM |
Atossa Therapeutics Announces Receipt of FDA Safe to | XenaLives | investorshub | 07/29/2021 5:35:25 AM |
About Atossa's Proprietary Endoxifen | XenaLives | investorshub | 07/29/2021 5:33:37 AM |
AG-1001-AU-02: AN $OPEN LABEL, PILOT AND EXPANSION PHARMACODYNAMIC | XenaLives | investorshub | 07/29/2021 5:30:40 AM |
Ownership info: | XenaLives | investorshub | 07/29/2021 5:21:07 AM |
Atossa Therapeutics Announces Pricing of $20.0 Million Underwritten | XenaLives | investorshub | 07/29/2021 5:17:04 AM |
Atossa Therapeutics Announces Second COVID-19 Therapeutic Development Pro | XenaLives | investorshub | 07/29/2021 5:13:43 AM |
znewcar1: Morning dip w/ S@5 and a strong finish. | znewcar1 | investorshangout | 07/12/2021 11:11:05 PM |
whytestocks: $ATOS News Article - The Bulls Are in Charge of Atossa Therapeutics | whytestocks | investorshangout | 07/06/2021 8:55:49 PM |
znewcar1: ATOS a BO>$8.5 and this could test $11 IMO | znewcar1 | investorshangout | 06/28/2021 6:48:53 PM |
whytestocks: $ATOS News Article - Can Atossa Therapeutics Stock Keep Climbing? | whytestocks | investorshangout | 06/28/2021 12:10:50 PM |
News, Short Squeeze, Breakout and More Instantly...
Atossa Therapeutics Inc. Company Name:
ATOS Stock Symbol:
NASDAQ Market:
Atossa Therapeutics Inc. Website:
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) study has fully...